Skip to main content
SpringerLink
Log in

Fluoroquinolone: no impact of regulatory interventions to reduce use in the EU/UK

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ly NF, et al. Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends. Drug Safety : 28 Mar 2023. Available from: URL: https://doi.org/10.1007/s40264-023-01286-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fluoroquinolone: no impact of regulatory interventions to reduce use in the EU/UK. Reactions Weekly 1951, 11 (2023). https://doi.org/10.1007/s40278-023-36788-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-36788-z

Search

Navigation